Photo of Dorna Jafari from X
Jun 29, 2024, 11:05
Neoadjuvant botensilimab and balstilimab in colorectal cancer
Smitha Krishnamurthi, Gastrointestinal medical oncologist at Cleveland Clinic, shared on X:
“Neoadjuvant botensilimab (1 dose) and balstilimab (4 doses) resulted in pathologic complete response in 5/9 patients with pMMR colorectal cancer!
Early results but super impressive.”
Source: Smitha Krishnamurthi/X